We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Endo Must Face Stock-Drop Claims In Opioid Safety Suit

Law360 (December 11, 2018, 1:56 PM EST) -- Endo International PLC and several of its executives must face an investor suit alleging the company knowingly misrepresented the safety of its Opana opioid, leading to a significant stock drop when...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Pennsylvania Eastern

Nature of Suit

890(Other Statutes: Other Statutory Actions)

Judge

Subscribers Only

Date Filed

August 18, 2017

Law Firms

Companies

Government Agencies

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.